Oct 2026
In primary membranous nephropathy, obinutuzumab increased the likelihood of complete remission vs. tacrolimus at 104 wk.
CLINICAL IMPACT RATINGS GIM/FP/GP: [Formula: see text] Nephrology: [Formula: see text].
M. Airy, W. Winkelmayer
· Annals of Internal Medicine · 0 citations